Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies.

Gaar-Humphreys, Karen R; van den Brink, Alyssa; Wekking, Mark; Asselbergs, Folkert W; van Steenbeek, Frank G; Harakalova, Magdalena; Pei, Jiayi

Gaar-Humphreys, Karen R; van den Brink, Alyssa; Wekking, Mark; Asselbergs, Folkert W; van Steenbeek, Frank G; Harakalova, Magdalena; Pei, Jiayi.

Afiliación

Gaar-Humphreys KR; Division Heart and Lungs, Department of Cardiology, Circulatory Health Research Center, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
van den Brink A; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht, Netherlands.
Wekking M; Division Heart and Lungs, Department of Cardiology, Circulatory Health Research Center, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Asselbergs FW; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht, Netherlands.
van Steenbeek FG; Division Heart and Lungs, Department of Cardiology, Circulatory Health Research Center, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands.
Harakalova M; Regenerative Medicine Center Utrecht, University Medical Center Utrecht, Utrecht, Netherlands.
Pei J; Department of Cardiology, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands.

Front Cardiovasc Med ; 10: 1114459, 2023.

Article en En | MEDLINE | ID: mdl-36760574

Palabras clave

dilated cardiomyopathy; fatty acid oxidation; genetic variants; hypertrophic cardiomyopathy; lipid metabolism; transcription factor PPARA

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Cardiovasc Med Año: 2023 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google